This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Regranex

Novartis AG

Drug Names(s): becaplermin

Description: The active ingredient of Regranex gel, becaplermin, is recombinant human platelet-derived growth factor (PDGF). This growth factor stimulates the migration of cells to the ulcer site, encouraging the patient's body to grow new tissue that heals the open wound.

Partners: Johnson & Johnson


Regranex News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug